BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory


OWKIN logo



AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

Analyzing patient data of today to find treatments of tomorrow.
OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, with offices in Paris and New York City.
Our data scientists and machine learning engineers are among the best in the world, with publications in ICML, NIPS and other top scientific journals, and the team includes several Kaggle Masters (top 100 worldwide) and a DREAM Challenge top performer.

Our proprietary platform, OWKIN Socrates, uses machine learning-based modeling to analyze molecular, imaging libraries and patient datasets to uncover complex biomarker patterns that cause disease. We partner with leading pharmaceutical companies including Amgen and Actelion and we have programs in development with Institut Curie, Centre Leon Berard and Saint Louis Hospital.

We aim to improve drug discovery and development using collective intelligence built on real-world patient data.

We transform hospitals full of unstructured datasets into thousands of accurate diagnostic and predictive models, augmenting and accelerating physicians’ capabilities. This real-world collective intelligence and access to data is transferable to the pharmaceutical industry and can empower predictive analytics, biomarker discovery and post-market analysis.

omics technology oncology biomedical images clinical data analytics

Posts Mentioning This Company

The Growing Momentum for AI Foundation Models in Biotech and 12 Notable Companies

As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic functions and industries, including biotech. The most prominent examples of general purpose foundation models are the GPT-3 and GPT-4 models, which form the basis of ChatGPT, and BERT, or Bidirectional …

9 Notable AI Companies in Clinical Research to Watch in 2023

The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even if the drug candidate is safe and efficacious, clinical trials might fail due to the lack of financing, insufficient enrollment, …

How Big Pharma Adopts AI To Boost Drug Discovery

(Last updated: July 2023) The type of artificial intelligence (AI) which scares business leaders, experts, and activists all over the world, is called “general artificial intelligence"—the  one which could “think” pretty much like humans do, and which could quickly evolve into a dangerous “superintelligence”. There is a notion that it …

First-of-its-kind AI-based Diagnostics Solutions Approved in Europe

According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 - nearly every 6th death worldwide happens because of this disease. Among all cancer cases, the top 3 types of cancer by incidence were breast (2.26 million cases), …

New Partnership Aims To Improve Kidney Cancer Treatment With AI

Owkin, a biotech startup that uses artificial intelligence (AI) for precision cancer therapy development is partnering with scientists from the Francis Crick Institute and The Royal Marsden NHS Foundation Trust in London to use AI to research how the evolution of a kidney cancer tumor is linked to differences in …

How Data-sharing Technologies Bolster AI Progress in Medical Research

While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving cars to name just a few), the pharmaceutical industry is yet to enjoy the full scale AI-driven transformation. Some companies did manage to demonstrate the power of artificial intelligence for …

Major VC Rounds For AI-driven Biotechs in 2020

The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- according to data by PitchBook biopharma venture deals in 2020 are down roughly 16% compared to last year.  However, there is still a lot going on in drug discovery and …

Virtual Immunostaining for Digital Pathology

Owkin is a French-American startup, backed by Google Ventures among others, that deploys Artificial Intelligence (AI) and Federated Learning for medical research. The company was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher at the École Normale Supérieure, and a …

Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery

Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry of artificial intelligence (AI) in healthcare and pharmaceutical research. They come together to announce mission and launch activities of a global Alliance for Artificial Intelligence in Healthcare (AAIH), which is …